SolasCure selected for innovate UK global incubator programme in houston

FHS
June 3, 2024
10:41 am

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, today announced it has been selected for Innovate UK’s Global Incubator Programme in Houston, US.

New center established to take the lead in enhancing living environments for all ages

The College of Design and Engineering (CDE) at the National University of Singapore (NUS) has established the Centre for Environment and Ageing Well (ENgAGE) to

August 27, 2024

The impact of AI and ChatGPT on health data – Pharmaceutical Technology

In the healthcare industry, AI is unlocking new possibilities and solving grand healthcare challenges by improving care outcomes, life science innovation, and patient experience in

July 18, 2023

Scholar Rock claims success in Phase 3 spinal muscular atrophy study, stock soars

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.